Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Ortin Global

ORTINGLOBE
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Ortin Global Share price and Fundamental Analysis

View All Details
View All Details
Ortin Laboratories Ltd is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.
Company Incorporation1986
ChairmanJ R K Panduranga Rao
Head QuartersNA
Previous NameOrtin Laboratories Ltd

Key Metrics

Market Cap (Cr)
9.74
PE Ratio
0
Industry P/E
34.24
PEG Ratio
0
ROE
-42.8%
ROCE
-37.48%
ROA
-22.22%
Total Debt (Cr)
0.25
Debt to Equity
0.13
Dividend Yield
0%
EPS
0
Book Value & P/B
2.44 x 4.92
Face Value
10
Outstanding Shares(Cr)
0.81
Current Ratio
2.15
EV to Sales
28.28

Stock Returns

1 Week+3.28%
1 Month+9.41%
6 Months-34.61%
1 Year-41.27%
3 Years-43.89%
5 Years-21.95%
no_data

No Stocks

Smart Score

1.4
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 1.23%

FIIs : 6.53%

DIIs : 0.00%

Public : 92.24%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
FII Shareholding Increased by 0.28% to 6.53% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Ortin Global Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Ortin Global Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Ortin Laboratories Ltd is a leading and predominant Pharmaceutical Manufacturer of Drugs and Medicines in India. The company is engaged in manufacture of Pharma formulations. They manufacture a range of pharmaceutical formulations of tablets, capsules, syrups, dry powders, and ointments in India. The company is having their manufacturing unit at Medak in Andhra Pradesh, which is equipped with technically modern manufacturing facilities to produce complete range of Pharmaceutical Formulations.

The company is an ISO 9001: 2000 certified company. They offer anti arthritic drugs, antibiotics, chemo therapeutics, analgesics and antipyretics, cardiac and cardio vascular drugs, anti diarroheal drugs, anti depressants, anti hypertensive, anti aids, anti tuberculosis drugs, gynaecological drugs, antibiotics, anti diabetic, antacids anti ulcer drugs, anti allergics, anti-cold, decongestants, antioxidents, vitamins, minerals, anti bacterial drugs, anti emetics, anti helmenthetics, nutritional supplements and protein, and appetizers. They also produce dental, ophthalmology, pediatric, diuretics, dermatology, psychiatry, and ENT drugs.

Ortin Laboratories Ltd, a Trusted Reliance for Quality was incorporated in the year 1986 as a private limited company with a nominal capital of Rs 1 lakh to offer quality Drugs and Medicines to the suffering mankind. In the year 1994, the company was converted into a public limited company.

The company constructed a Factory in a spacious area of 25,000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of tablets capsules syrups dry powders & ointments. During the year 2003-04, the company started their second division of products and marketing in few states.

During the year 2006-07, the company got listed their shares in BSE- Indonext model, which provided a nation-wide trading platform for the investors of the company for their effective participation. They completed the up gradation of factory premises as per Revised Schedule M and started exporting their products to Asian, African countries and Middle East countries.

During the year 2009-10, the company acquired the certification for the registration with National Drug Authority, Uganda wherein the company has got the eligibility to export their products to Uganda.

During the year 2010-11, Vineet Laboratories Pvt Ltd, a private limited company engaged in the manufacturing of Fine Chemicals, Custom synthesis and specialized in making bulk drug intermediates for anti retrovirals and lipid lowering agents, etc was amalgamated with the company. Also, the company was allotted 6.18 acres of land in IDA, Buchinelli, Zaheerabad, Medak Dist., AP by APIIC. The company is planning to construct USFDA and European Standard Bulk Drug manufacturing facility.

Ortin Global Share Price

Ortin Global share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Ortin Global Market Cap

Market capitalization of Ortin Global indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Ortin Global is valued compared to its competitors.

Ortin Global PE Ratio

Ortin Global PE ratio helps investors understand what is the market value of each stock compared to Ortin Global 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Ortin Global PEG Ratio

The PEG ratio of Ortin Global evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Ortin Global ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Ortin Global generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Ortin Global ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Ortin Global in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Ortin Global Total Debt

Total debt of Ortin Global shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Ortin Global Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Ortin Global compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Ortin Global CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Ortin Global over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Ortin Global Technical Analysis

Technical analysis of Ortin Global helps investors get an insight into when they can enter or exit the stock. Key components of Ortin Global Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Ortin Global shares often struggle to rise above due to selling pressure.

Ortin Global Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Ortin Global ’s financial health and profitability.

Ortin Global Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Ortin Global Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Ortin Global Financials

The financials of Ortin Global provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Ortin Global Profit and Loss Statements

The profit and loss statement of Ortin Global highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Ortin Global .

Ortin Global Balance Sheet

The balance sheet presents a snapshot of Ortin Global ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Ortin Global Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.